1 active not recruiting, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
Follow Sham Acute Intermittent Hypoxia: new trials by email Literature Review of Sham Acute Intermittent Hypoxia trials Research Report on Sham Acute Intermittent Hypoxia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adenosine 2A Receptor Antagonism and AIH in ALS Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug - ALS | Phase 1 / Phase 2 | Active not recruiting | University of Florida | 40 | 2022-06-21 | 2026-03-27 |
| Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia - Spinal Cord Injuries | Phase 1 / Phase 2 | Unknown | Shirley Ryan AbilityLab | 24 | 2016-05-01 | 2020-02-19 |
Hypoxia (1) · Respiratory Aspiration (1) · Spinal Cord Injuries (1)
Shirley Ryan AbilityLab (1) · University of Florida (1)
United States (2)
Barbara Smith (1)